Enzyme Replacement Therapy Market Set To Surge Due To Escalating Prevalence Of Chronic And Inherited Disorders: The Driving Engine Behind Enzyme Replacement Therapy Market Evolution in 2025

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Enzyme Replacement Therapy Market Size Growth Forecast: What to Expect by 2025?
The market for enzyme replacement therapy has seen significant expansion over the past few years. The size of the market is projected to increase from $11.58 billion in 2024 to $12.48 billion in 2025, indicating a compound annual growth rate (CAGR) of 7.8%. Factors that have contributed to the growth in the past include breakthroughs in early therapeutic discoveries, approvals for cutting-edge treatments, aggregated knowledge about diseases, favorable outcomes in clinical trials, and incentives and support from regulatory bodies.

How Will the Enzyme Replacement Therapy Market Size Evolve and Grow by 2029?
There is an anticipated significant expansion in the enzyme replacement therapy market in the coming years, with forecasts predicting it will reach "$17.81 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.3%. Factors like enhanced patient access to healthcare services, customized therapies and personal medicine, alterations in the regulatory framework, and heightened awareness among the patient population are contributing to this predicted growth. The forthcoming period will also witness key trends such as the incorporation of digital health, emphasis on solutions centered around the patient, novel biomarker research, and the implementation of precision medicine.

View the full report here:
https://www.thebusinessresearchcompany.com/report/enzyme-replacement-therapy-global-market-report

What Drivers Are Propelling the Growth of Enzyme Replacement Therapy Market Forward?
The enzyme replacement therapy market is anticipated to expand due to the increasing occurrence of rare, chronic, and inherited diseases. Chronic illnesses are conditions that persist for longer than three months and often worsen over time. These illnesses are particularly common among the elderly population and they are often manageable, but not curable. The American Lung Association, a nonprofit organization based in the US, reported in July 2024 that in 2022, 44.2 million Americans, representing 13.5% of the population, had been medically diagnosed with asthma; this indicates an increase from the 12.9% reported in 2021. As such, the higher occurrence of rare, chronic, and inherited diseases is projected to stimulate the expansion of the enzyme replacement therapy market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample_request?id=10512&type=smp

Which Emerging Trends Are Transforming the Enzyme Replacement Therapy Market in 2025?
The primary trend within the enzyme replacement therapy market is product approvals. Numerous therapies have received market authorization, reflecting the increased acceptance and growing popularity of these treatments. For example, in February 2023, Lamzede (velmanase alfa) was approved by the Food and Drug Administration (FDA), an American federal health department entity. This was a landmark moment because it was the country's first authorized enzyme replacement therapy for non-central neurological indications of alpha-mannosidosis, a rare genetic disorder marked by the lack of an alpha-mannosidase enzyme. Lamzede enhances normal cellular activities in patients by mimicking the function of the absent enzyme. It is usually administered as a 10mg injection once a week, aiding in healthy cellular functioning.

What Are the Key Segments in the Enzyme Replacement Therapy Market?
The enzyme replacement therapy market covered in this report is segmented -

1) By Enzyme Type: Agalsidase Alfa, Agalsidase Beta, Galsulfase, Other Enzyme Types
2) By Route Of Administration: Oral, Parenteral
3) By Application: Gaucher Disease, Pompe Disease, Fabry Disease, Other Applications
4) By End-Users: Hospitals, Infusion Centers, Other End-Users

Subsegments:
1) By Agalsidase Alfa: Fabry Disease Treatment
2) By Agalsidase Beta: Fabry Disease Treatment
3) By Galsulfase: Mucopolysaccharidosis VI (MPS VI) Treatment
4) By Other Enzyme Types: Alglucosidase Alfa, Idursulfase, Velaglucerase Alfa

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/Customise?id=10512&type=smp

Who Are the Key Players Shaping the Enzyme Replacement Therapy Market's Competitive Landscape?
Major companies operating in the enzyme replacement therapy market include Biomarin Pharmaceutical Inc., Leadiant Biosciences Inc., Pfizer Inc., Sanofi S.A., AbbVie Inc., Johnson & Johnson Services Inc., Alexion Pharmaceuticals Inc., Recordati Rare Diseases Inc., Sangamo Therapeutics Inc., JCR Pharmaceuticals Co. Ltd., Horizon Pharma Public Limited Company, Protalix Biotherapeutics Ltd., Amicus Therapeutics Inc., AstraZeneca plc, Novartis AG, Roche Holding AG, GlaxoSmithKline plc, Merck & Co. Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, Retrophin Inc., Abeona Therapeutics Inc., Orchard Therapeutics plc, Ultragenyx Pharmaceutical Inc.

What Geographic Markets Are Powering Growth in the Enzyme Replacement Therapy Market?
North America was the largest region in the enzyme replacement therapy market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global enzyme replacement therapy market report during the forecast period. The regions covered in the enzyme replacement therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10512

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.